Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2005, p. 2822-2827, Vol. 49, No. 7
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.7.2822-2827.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts,1 Department of Dermatology, Harvard Medical School, Boston, Massachusetts,2 Sterilite LLC, Minnetonka, Minnesota,3 Department of Gastroenterology, Abbott-Northwestern Hospital, Minneapolis, Minnesota,4 Seedling Ventures LLC, Boston, Massachusetts5
Received 21 September 2004/ Returned for modification 22 September 2004/ Accepted 7 March 2005
Helicobacter pylori colonizes the mucus layer of the human stomach and duodenum, causes chronic gastritis, gastric ulcer, and is a risk factor for gastric adenocarcinoma. There is a 20% failure rate in antibiotic therapy, which is increasingly due to antibiotic resistance and necessitates the search for alternative antimicrobial methods. We have discovered that H. pylori when cultured in liquid medium, accumulates significant quantities of coproporphyrin and protoporphyrin IX, both in the cells and secreted into the medium. These photoactive porphyrins lead to cell death (up to 5 logs) by photodynamic action upon illumination with low doses of visible light, with blue/violet light being most efficient. The degree of killing increases with the age of the culture and is greater than that found with Propionibacterium acnes (another bacterium known to be photosensitive due to porphyrin accumulation). Both virulent and drug-resistant strains are killed. The data suggest that phototherapy might be used to treat H. pylori infection in the human stomach.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»